Followers | 916 |
Posts | 48163 |
Boards Moderated | 0 |
Alias Born | 07/22/2008 |
![](https://investorshub.advfn.com/uicon/129869.png?cb=1705717490)
Tuesday, February 14, 2023 12:15:56 AM
Market cap is currently $2.5 million @ $0.0209. Looking for additional PATENT news and PARTNERSHIP news :)
![](http://investorshub.advfn.com/uimage/uploads/2023/2/11/prqqs0_-_qbio_logo_old.png)
648 views Jul 26, 2022
Q BioMed Inc CEO Denis Corin says a new study that shows the superior safety and efficacy of its Uttroside-B chemotherapeutic versus FDA-approved drug Sorafenib adds weight to the promise of an effective therapeutic for a patient population that desperately needs better and more treatment options.
Corin told Proactive that the study provides additional data for Q BioMed to present to potential partners.
"Our objective with this asset has always been to develop it and hopefully partner it with large pharma who are interested in this space," Corin added.
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM